Frank J. Lanza SEC EDGAR Filings (CIK 0001624055)

SEC EDGAR filings, ownership reports, and insider transactions for Frank J. Lanza.

Business address
C/O Harpoon Therapeutics, Inc., 131 Oyster Point Boulevard, Suite 300, South San Francisco, CA, 94080
Get insider transactions for this reporting owner
Frank J. Lanza has filed 7 SEC EDGAR filings since 04 Nov 2014

Latest Filings

Recent SEC filings for Frank J. Lanza including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 11 Mar 2024 11 Mar 2024 001-38800
4 Open 4 document View SEC filing for 4 4 09 Jan 2024 07 Jan 2024 001-38800
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 Nov 2023 26 Nov 2023 001-38800
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Jan 2023 24 Jan 2023 001-38800
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 29 Nov 2022 22 Nov 2022 001-38800
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 19 Sep 2022 15 Sep 2022 001-38800
3 Open 3 document View SEC filing for 3 FORM 3 04 Nov 2014 23 Oct 2014 000-25571

About this filer

Frank J. Lanza files with the SEC under CIK 0001624055. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages